Zelalem Eshete

Array ( [id] => 4860416 [patent_doc_number] => 20080269266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'NOVEL COMPOUNDS 747' [patent_app_type] => utility [patent_app_number] => 12/055658 [patent_app_country] => US [patent_app_date] => 2008-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16765 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269266.pdf [firstpage_image] =>[orig_patent_app_number] => 12055658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603488 [patent_doc_number] => 20100063013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'CATHEPSIN CYSTEINE PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/532652 [patent_app_country] => US [patent_app_date] => 2008-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31685 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063013.pdf [firstpage_image] =>[orig_patent_app_number] => 12532652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322640 [patent_doc_number] => 07517873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Substituted pyrimidodiazepines' [patent_app_type] => utility [patent_app_number] => 12/051000 [patent_app_country] => US [patent_app_date] => 2008-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48709 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517873.pdf [firstpage_image] =>[orig_patent_app_number] => 12051000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860344 [patent_doc_number] => 20080269194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Compositions And Methods Relating To Novel Compounds And Targets Thereof' [patent_app_type] => utility [patent_app_number] => 12/044589 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38778 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269194.pdf [firstpage_image] =>[orig_patent_app_number] => 12044589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 267193 [patent_doc_number] => 07566719 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-28 [patent_title] => 'Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors' [patent_app_type] => utility [patent_app_number] => 12/043421 [patent_app_country] => US [patent_app_date] => 2008-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31618 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/566/07566719.pdf [firstpage_image] =>[orig_patent_app_number] => 12043421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6507566 [patent_doc_number] => 20100210597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'C21-Deoxy Ansamycin Derivatives as Antitumor Agents' [patent_app_type] => utility [patent_app_number] => 12/526605 [patent_app_country] => US [patent_app_date] => 2008-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 28231 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210597.pdf [firstpage_image] =>[orig_patent_app_number] => 12526605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880421 [patent_doc_number] => 20080153804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Gamma D-Crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 12/072887 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1416 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153804.pdf [firstpage_image] =>[orig_patent_app_number] => 12072887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880420 [patent_doc_number] => 20080153803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Gamma-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 12/072793 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1496 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153803.pdf [firstpage_image] =>[orig_patent_app_number] => 12072793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753211 [patent_doc_number] => 20080161286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Beta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 12/072577 [patent_app_country] => US [patent_app_date] => 2008-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1374 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161286.pdf [firstpage_image] =>[orig_patent_app_number] => 12072577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753210 [patent_doc_number] => 20080161285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 12/072461 [patent_app_country] => US [patent_app_date] => 2008-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1548 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161285.pdf [firstpage_image] =>[orig_patent_app_number] => 12072461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6445435 [patent_doc_number] => 20100144715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Substituted Benzodiazepinones, Benzoxazepinones and Benzothiazepinones as Sodium Channel Blockers' [patent_app_type] => utility [patent_app_number] => 12/528041 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17874 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144715.pdf [firstpage_image] =>[orig_patent_app_number] => 12528041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718767 [patent_doc_number] => 20080241289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'PREPARATION AND UTILITY OF NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/035763 [patent_app_country] => US [patent_app_date] => 2008-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31007 [patent_no_of_claims] => 124 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241289.pdf [firstpage_image] =>[orig_patent_app_number] => 12035763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6449611 [patent_doc_number] => 20100145003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Catalytic Deamination for Caprolactam Production' [patent_app_type] => utility [patent_app_number] => 12/527848 [patent_app_country] => US [patent_app_date] => 2008-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9067 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0145/20100145003.pdf [firstpage_image] =>[orig_patent_app_number] => 12527848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753209 [patent_doc_number] => 20080161284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Delta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it.' [patent_app_type] => utility [patent_app_number] => 12/070608 [patent_app_country] => US [patent_app_date] => 2008-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1411 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161284.pdf [firstpage_image] =>[orig_patent_app_number] => 12070608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880471 [patent_doc_number] => 20080153854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'NOVEL FUSED HETEROCYCLES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/032438 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87717 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153854.pdf [firstpage_image] =>[orig_patent_app_number] => 12032438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4463755 [patent_doc_number] => RE042375 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2011-05-17 [patent_title] => 'Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors' [patent_app_type] => reissue [patent_app_number] => 12/069553 [patent_app_country] => US [patent_app_date] => 2008-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33310 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/042/RE042375.pdf [firstpage_image] =>[orig_patent_app_number] => 12069553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146889 [patent_doc_number] => 08163899 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Process for producing laurolactam' [patent_app_type] => utility [patent_app_number] => 12/526494 [patent_app_country] => US [patent_app_date] => 2008-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10060 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163899.pdf [firstpage_image] =>[orig_patent_app_number] => 12526494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8208989 [patent_doc_number] => 20120128657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'SYNTHETIC MACROCYCLIC COMPOUNDS AND METHODS FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 12/526477 [patent_app_country] => US [patent_app_date] => 2008-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14029 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128657.pdf [firstpage_image] =>[orig_patent_app_number] => 12526477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 267252 [patent_doc_number] => 07566778 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-28 [patent_title] => '(Pyrido/thieno)-[f]-oxazepine-5-one derivatives' [patent_app_type] => utility [patent_app_number] => 12/024597 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7442 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/566/07566778.pdf [firstpage_image] =>[orig_patent_app_number] => 12024597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 803329 [patent_doc_number] => 07423033 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-09 [patent_title] => 'Hydroxyalkanoylaminolactams and related structures as inhibitors of aβ protein production' [patent_app_type] => utility [patent_app_number] => 12/024812 [patent_app_country] => US [patent_app_date] => 2008-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46861 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/423/07423033.pdf [firstpage_image] =>[orig_patent_app_number] => 12024812 [rel_patent_id] =>[rel_patent_doc_number] =>)